- Summary
- Price Reports
- Price History
- Add To Your Stocklist
- View your Stocklist
- Basic Chart
- Interactive Chart
- Headlines
- Company Snapshot
- Summary Reports
- Free Annual Report
- Estimate Snapshot
- Estimate Report
- Mobile Quote
- Real-Time Quote
- Streaming Quote
|
Life Technologies | Company Snapshot
-
![]()
-
-
-
Vol:
-
Last Trade:
|
LIFE TECHNOLOGIES CORPORATION
Invitrogen Corporation provides products and services that support academic and government research institutions and pharmaceutical and biotech companies worldwide in their efforts to improve the human condition. The company provides essential life science technologies for disease research, drug discovery, and commercial bioproduction. Invitrogen's own research and development efforts are focused on breakthrough innovation in all major areas of biological discovery including functional genomics, proteomics, bioinformatics and cell biology placing Invitrogen's products in nearly every major laboratory in the world.
|
|
| Symbol: |
LIFE |
| Exchange(s): |
Nasdaq Stock Market |
| Industry: |
Consumer Products (Biotechnology & Pharmaceuticals) |
| 5-Star Rating: |
 |
|
ANNUAL FINANCIALS
|
|
|
Dec 31, 2009
12 Months
us$
|
Dec 31, 2008
12 Months
us$
|
Dec 31, 2007
12 Months
us$
|
3Yr.
Growth
% Change
|
|
Total Revenue ($000)
|
3,280,340
|
1,620,320
|
1,281,740
|
37.44
|
|
Earnings before Interest & Tax ($000)
|
387,450
|
197,290
|
206,600
|
N/A
|
|
Profit/Loss ($000)
|
144,590
|
29,960
|
130,270
|
N/A
|
|
Earnings per Share
|
0.82
|
0.32
|
1.53
|
N/A
|
|
Total Assets ($000)
|
9,115,860
|
8,913,910
|
3,329,740
|
42.01
|
|
Dividends Per Share
|
0.00
|
0.00
|
0.00
|
|
|
Return on Com. Equity
|
3.89
|
1.21
|
8.43
|
|
|
Employees
|
N/A
|
N/A
|
N/A
|
|
|
|
|
|
Trailing 12 Month Results
|
|
|
12 Months ended
Dec 31, 2009,us$
|
12 Months ended
Dec 31, 2008,us$
|
%Change
|
|
Total Revenue ($000)
|
3,280,340
|
1,620,330
|
102.45
|
|
Profit/Loss ($000)
|
144,630
|
31,320
|
361.78
|
|
Earnings per Share
|
0.81
|
0.60
|
35.00
|
|
Dividends Per Share
|
0.00
|
0.00
|
|
Number of Shares
|
178,340,000
|
92,360,000
|
|
|
|
|
|
COMPANY INFORMATION
|
| Key Personnel |
| CEO: Gregory T. Lucier, Chmn.; C.E.O.; Dir. |
| CFO: David F. Hoffmeister, C.F.O. |
| |
| Contact Information |
| Address: |
1600 Faraday Avenue,
Carlsbad,
CA,
92008 |
Phone: |
760-603-7200 |
| Fax: |
760-602-6500 |
| Web Address: |
www.invitrogen.com |
| E-Mail : |
ir@invitrogen.com |
| |
| Incorporation:
| United States |
| |
|
Securities:
|
LIFE-Q
|
|
| |
|
|
| |
|
|
Financial data is provided by Zacks Investment Research.
| |
All information on this site is compiled by CTVglobemedia Publishing Inc. from reliable industry sources. While all efforts are made to ensure the accuracy of the information, CTVglobemedia Publishing Inc. and its related entities assume no liability for incorrect, incomplete, or missing information from this site. Past performance is not necessarily indicative of future performance. Prior to making any investment decision, consult with a qualified investment advisor.
Copyright © 2010 CTVglobemedia Publishing Inc. All rights reserved.
|
|
|
